4.980USD+5.29%Mkt Cap: 153.27M $P/E: —1d ago
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is th…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap153.27M $
Enterprise Value187.13M $
Revenue (TTM)72.35M $
Gross Profit58.82M $
Net Income (TTM)-48.59M $
Revenue/Share2.501 USD
Last Price4.980 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees226
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.40
PEG—
EV/EBITDA-5.04
EV/Revenue2.59
P/S2.12
P/B-6.61
EPS (TTM)-1.56
EPS (Forward)-0.59
52W Range
3.22045% of range7.120
52W High7.120 USD
52W Low3.220 USD
Profitability
Gross Margin82.13%
Oper. Margin-45.73%
EBITDA Margin-51.29%
Profit Margin-67.85%
ROE291.81%
ROA-86.16%
Growth
Revenue Growth4.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.20M $
CapEx (TTM)1.74M $
FCF Margin-25.31%
FCF Yield-11.95%
Net Debt33.86M $
Net Debt/EBITDA-0.91
Balance Sheet
Debt/Equity-2.77
Current Ratio0.47
Quick Ratio0.36
Book Value/Sh-0.7530 USD
Cash/Share0.4630 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJun 30, 2020
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)9.102 USD
Upside (mean)+82.8%
Target Range6.067 USD – 12.14 USD
$6.067+82.8% to mean$12.14
# Analysts2
Ownership
Shares Out.30.78M
Float30.30M
Insiders1.52%
Institutions17.16%
Short Interest
Short Ratio7.7d
Short % Float8.30%
Short % Out.8.22%
Shares Short2.53M
Short (prev mo.)3.30M
Technical
SMA 504.267 (+16.7%)
SMA 2004.202 (+18.5%)
Beta1.86
S&P 52W Chg20.25%
Avg Vol (30d)346.62K
Avg Vol (10d)339.88K
Technical Indicators
RSI (14)60.8
MACD0.1027
MACD Signal0.0648
MACD Hist.+0.0379
BB Upper5.211 USD
BB Middle4.306 USD
BB Lower3.400 USD
BB Width42.07%
ATR (14)0.4100 USD
Vol Ratio (20d)2.41x